gp130-Mediated Signaling Is Necessary for Normal Osteoblastic Function in Vivo and in Vitro

Endocrinology

Volumn 145, Issue 3, 2004, Pages 1376-1385

  Shin, Hong In ^a,e   Divieti, Paola ^a   Sims, Natalie A ^b,f   Kobayashi, Tatsuya ^a   Miao, Dengshun ^c   Karaplis, Andrew C ^d   Baron, Roland ^b   Bringhurst, Richard ^a   Kronenberg, Henry M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e Department of Nursing   (South Korea)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; GLYCOPROTEIN GP 130; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; PARATHYROID HORMONE; PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM HOMEOSTASIS; CALVARIA; CELL FUNCTION; CELL ORGANELLE; CONTROLLED STUDY; FETUS; HYPERPARATHYROIDISM; HYPOCALCEMIA; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD; BONE AND BONES; BONE DEVELOPMENT; CALCIUM; CARRIER PROTEINS; CELLS, CULTURED; CYTOKINE RECEPTOR GP130; FEMALE; HOMEOSTASIS; HYPERPARATHYROIDISM, SECONDARY; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; MICE, MUTANT STRAINS; OSTEOBLASTS; OSTEOCLASTS; PARATHYROID HORMONE; PLACENTA; PREGNANCY; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RNA, MESSENGER; SIGNAL TRANSDUCTION; SOLUBILITY;

EID: 1442323644     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0839     Document Type: Article

References (27)

1. Heymann D, Rousselle AV 2000 gp130 Cytokine family and bone cells. Cytokine 12:1455-1468
2. Bravo J, Heath JK 2000 Receptor recognition by gp130 cytokines. EMBO J 19:2399-2411
3. Bellido T, Stahl N, Farruggella TJ, Borba V, Yancopoulos GD, Manolagas SC 1996 Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. J Clin Invest 97:431-437
4. Udagawa N, Takahashi N, Katagiri T, Tamura T, Wada S, Findlay DM, Martin TJ, Hirota H, Taga T, Kishimoto T 1995 Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J Exp Med 182:1461-1468
5. Cappellen D, Luong-Nguyen NH, Bongiovanni S, Grenet O, Wanke C, Susa M 2002 Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFκB. J Biol Chem 277:21971-21982
6. Malaval L, Gupta AK, Liu F, Delmas PD, Aubin JE 1998 LIF, but not IL-6, regulates osteoprogenitor differentiation in rat calvaria cell cultures: modulation by dexamethasone. J Bone Miner Res 13:175-184
7. Bellido T, Borba VZ, Roberson P, Manolagas SC 1997 Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation. Endocrinology 138:3666-3676
8. Romas E, Udagawa N, Zhou H, Tamura T, Saito M, Taga T, Hilton DJ, Suda T, Ng KW, Martin TJ 1996 The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures. J Exp Med 183:2581-2591
9. Adebanjo OA, Moonga BS, Yamate T, Sun L, Minkin C, Abe E, Zaidi M 1998 Mode of action of interleukin-6 on mature osteoclasts. Novel interactions with extracellular Ca2+ sensing in the regulation of osteoclastic bone resorption. J Cell Biol 142:1347-1356
10. Greenfield EM, Shaw SM, Gornik SA, Banks MA 1995 Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption. J Clin Invest 96:1238-1244
11. Pollock JH, Blaha MJ, Lavish SA, Stevenson S, Greenfield EM 1996 In vivo demonstration that parathyroid hormone and parathyroid hormone-related protein stimulate expression by osteoblasts of interleukin-6 and leukemia inhibitory factor. J Bone Miner Res 11:754-759
12. Grey A, Mitnick MA, Masiukiewicz U, Sun BH, Rudikoff S, Jilka RL, Manolagas SC, Insogna K 1999 A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo. Endocrinology 140:4683-4690
13. O'Brien CA, Gubrij I, Lin SC, Saylors RL, Manolagas SC 1999 STAT3 activation in stromal/osteoblastic cells is required for induction of the receptor activator of NP-κB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1, 25-dihydroxyvitamin D3 or parathyroid hormone. J Biol Chem 274:19301-19308
14. Yoshida K, Taga T, Saito M, Suematsu S, Kumanogoh A, Tanaka T, Fujiwara H, Hirata M, Yamagami T, Nakahata T, Hirabayashi T, Yoneda Y, Tanaka K, Wang WZ, Mori C, Shiota K, Yoshida N, Kishimoto T 1996 Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci USA 93:407-411
15. Kawasaki K, Gao YH, Yokose S, Kaji Y, Nakamura T, Suda T, Yoshida K, Taga T, Kishimoto T, Kataoka H, Yuasa T, Norimatsu H, Yamaguchi A 1997 Osteoclasts are present in gp130-deficient mice. Endocrinology 138:4959-4965
16. Ware CB, Horowitz MC, Renshaw BR, Hunt JS, Liggitt D, Koblar SA, Gliniak BC, McKenna HJ, Papayannopoulou T, Thoma B 1995 Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 121(Suppl):1283-1299
17. Kovacs CS, Lanske B, Hunzelman JL, Guo J, Karaplis AC, Kronenberg HM 1996 Parathyroid hormone-related peptide (PTHrP) regulates fetal-placental calcium transport through a receptor distinct from the PTH/PTHrP receptor. Proc Natl Acad Sci USA 93:15233-15238
18. Nifuji A, Kellermann O, Kuboki Y, Wozney JM, Noda M 1997 Perturbation of BMP signaling in somatogenesis resulted in vertebral and rib malformations in the axial skeletal formation. J Bone Miner Res 12:332-342
19. Angerer L, Angerer R 1995. In situ hybridization to cellular RNA with radio-labelled RNA probes. In: Wilkinson DG, ed. In situ hybridization: a practical approach. New York: Oxford University Press; 15-32
20. Baron R, Vignery A, Neff L, Silverglate A, Maria AS 1983. In: Recker R, ed. Bone histomorphometry: techniques and interpretation. Boca Raton, FL: CRC Press; 13-35
21. Miao D, He B, Karaplis AC, Goltzman D 2002 Parathyroid hormone is essential for normal fetal bone formation. J Clin Invest 109:1173-1182
22. Jilka RL, Weinstein RS, Bellido T, Parfitt AM, Manolagas SC 1998 Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res 13:793-802
23. Kovacs CS, Kronenberg HM 1997 Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev 18:832-872
24. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ 1999 Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20:345-357
25. Udagawa N, Takahashi N, Yasuda H, Mizuno A, Itoh K, Ueno Y, Shinki T, Gillespie MT, Martin TJ, Higashio K, Suda T 2000 Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology 141:3478-3484
26. Ma YL, Cain RL, Halladay DL, Yang X Zeng Q, Miles RR, Chandrasekhar S, Martin TJ, Onyia JE 2001 Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology 142:4047-4054
27. Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T 1999 Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-κ B ligand. Bone 25:517-523